Skip to main content
TipRanks
Go Ultimate75% OFF

Prince Pharmaceutical Co., Ltd. (6935) Financial Statements

Prince Pharmaceutical Co., Ltd. Financial Overview

Prince Pharmaceutical Co., Ltd.'s market cap is currently NT$1.34B. The company's EPS TTM is NT$3.53; its P/E ratio is 7.99; and it has a dividend yield of 1.74%. Prince Pharmaceutical Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 1.06BNT$ 690.02MNT$ 753.33MNT$ 712.53MNT$ 441.08M
Gross ProfitNT$ 222.55MNT$ 74.28MNT$ 153.09MNT$ 205.79MNT$ 125.49M
Operating IncomeNT$ 110.88MNT$ -49.35MNT$ 25.68MNT$ 67.85MNT$ -1.11M
EBITDANT$ 175.94MNT$ 20.68MNT$ 88.19MNT$ 125.58MNT$ 43.47M
Net IncomeNT$ 96.32MNT$ -53.54MNT$ 15.31MNT$ 51.55MNT$ -8.30M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 152.62MNT$ 102.80MNT$ 122.57MNT$ 71.96MNT$ 72.50M
Total AssetsNT$ 1.50BNT$ 1.35BNT$ 1.41BNT$ 1.30BNT$ 1.29B
Total DebtNT$ 422.03MNT$ 460.80MNT$ 490.36MNT$ 523.11MNT$ 565.99M
Net DebtNT$ 269.41MNT$ 357.99MNT$ 367.79MNT$ 451.15MNT$ 493.49M
Total LiabilitiesNT$ 664.81MNT$ 626.19MNT$ 636.47MNT$ 645.91MNT$ 687.77M
Stockholders' EquityNT$ 838.67MNT$ 722.06MNT$ 774.47MNT$ 658.38MNT$ 602.87M
Cash Flow
Free Cash FlowNT$ 71.25MNT$ 28.21MNT$ 256.00KNT$ 71.84MNT$ 1.08M
Operating Cash FlowNT$ 90.06MNT$ 46.21MNT$ 62.50MNT$ 91.65MNT$ 42.36M
Investing Cash FlowNT$ -19.54MNT$ -17.32MNT$ -68.01MNT$ -40.02MNT$ -38.79M
Financing Cash FlowNT$ -20.70MNT$ -48.65MNT$ 56.11MNT$ -52.17MNT$ 11.86M

Currency in TWD

Prince Pharmaceutical Co., Ltd. Earnings and Revenue History

-600M0600M1.2B-24 %-12 %0 %12 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin

Prince Pharmaceutical Co., Ltd. Liabilities to Assets

0600M1.2B1.8B40 %45 %50 %55 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Prince Pharmaceutical Co., Ltd. Cash Flow

-300M-200M-100M0100M200M2019202020212022202320242025OperatingInvestingFinancing

Prince Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS